Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published September 26, 2020 | Version v1
Journal article Open

Advancement level of mobile applications intended for type 1 diabetes therapy supporting

Description

Nowicki Tomasz, Nowicki Grzegorz, Ślusarska Barbara. Advancement level of mobile applications intended for type 1 diabetes therapy supporting. Journal of Education, Health and Sport. 2020;10(9):704-713. eISSN 2391-8306. DOI http://dx.doi.org/10.12775/JEHS.2020.10.09.085

https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/JEHS.2020.10.09.085

https://zenodo.org/record/4050997

 

 

 

 

 

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

© The Authors 2020;

This article is published with open access at Licensee Open Journal Systems of Nicolaus Copernicus University in Torun, Poland

Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license Share alike.

(http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited.

The authors declare that there is no conflict of interests regarding the publication of this paper.

 

Received: 21.09.2020. Revised: 24.09.2020. Accepted: 26.09.2020.

 

 

 

 

 

 

 

 

 

 

 

 

 

Advancement level of mobile applications intended for type 1 diabetes therapy supporting

 

Tomasz Jerzy Nowicki1, Grzegorz Józef Nowicki2, Barbara Ślusarska3

 

1. Department of Internet of Things, Institute of Computer Science, Electrical Engineering and Computer Science Faculty, Lublin University of Technology

2. Department of Family Medicine and Community Nursing, Chair of Oncology and Environmental Health, Faculty of Health Sciences, Medical University of Lublin, Poland

 

Tomasz Jerzy Nowicki (ORCID: 0000-0003-0752-2509; e-mail: t.nowicki@pollub.pl),

Grzegorz Józef Nowicki (ORCID: 0000-0002-0503-8847; e-mail: gnowicki84@gmail.com),

Barbara Ślusarska (ORCID: 0000-0003-0101-9216; e-mail: basiaslusarska@gmail.com)

 

 

ABSTRACT

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycaemia due to defective secretion and/or action of insulin. Chronic hyperglycaemia is associated with damage, dysfunction, and failure of various organs, in particular eyes, kidneys, nerves, heart, and blood vessels.  It is estimated that the number of patients with type 1 diabetes accounts for about 10% of all diabetics, even more children and young adults i.e. under 30 constitute between 85 – 90 % of morbidities.  The fundamental part of type 1 diabetes therapy is providing patient with an external insulin therapy. The objective of this research was to formulate requirements concerning mobile applications for diabetes 1 therapy as well as an overview and a classification of such applications currently available. This paper includes a set of 20 requirements for mobile applications intended for type 1 diabetes patients. Some of them are beyond the possibilities of the modern-day IT industry. Nowadays there is no applications that meets all of the criteria. However, the tendency to fulfill all of them can be noticed.

 

Key words: type 1 diabetes mellitus, therapy of type 1 diabetes, mobile applications

Files

31438.pdf

Files (450.2 kB)

Name Size Download all
md5:da6cf442bdbd969000bca9dc2e245527
450.2 kB Preview Download